OTC · Industrials

Pharmagreen Biotech Inc. (PHBI)

It posted a net loss of $875.5K. At June 30, 2023 it held $5.3K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2023.

Watch PHBI in 60 seconds

Price

$0.33

-62.89% on the day · August 18, 2026

52-week range $0.00 to $7.00

Market cap

$167.5M

What Pharmagreen Biotech Inc. does

Pharmagreen Biotech Inc. is registered with the SEC under industry code SIC 4581 (Airports, Flying Fields & Airport Terminal Services). Its shares trade on OTC under the ticker PHBI.

Revenue and profit by year

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2022	n/a	-$1.1M	-$875.5K	n/a	n/a
2021	n/a	-$744.1K	-$4.5M	-$0.02	n/a
2020	n/a	-$485.8K	-$2.5M	-$0.03	n/a
2019	n/a	-$642.2K	-$767.5K	-$0.01	-$514K
2019	n/a	-$748.7K	-$1.1M	-$0.04	-$1M

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Pharmagreen Biotech Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

December 1, 2023
Deregistration 15-12G
August 14, 2023
Quarterly report 10-Q · period to June 30, 2023Revenue was $597; net loss of $162.9K versus net income of $251.9K.
May 19, 2023
Quarterly report 10-Q · period to March 31, 2023Revenue was $963; operating margin was -19,520.5%.
May 18, 2023
Auditor change 8-K
May 12, 2023
Late quarterly report notice NT 10-Q
February 14, 2023
Quarterly report 10-Q · period to December 31, 2022Net loss of $39.4K versus net income of $18.7K.
January 17, 2023
Annual report 10-K · period to September 30, 2022Net loss of $875.5K.
December 28, 2022
Late annual report notice NT 10-K
December 2, 2022
Material agreement 8-K
August 17, 2022
Quarterly report 10-Q · period to June 30, 2022Diluted EPS was $0.00.

All filings on SEC EDGAR

Questions about PHBI

What does Pharmagreen Biotech Inc. do?

Pharmagreen Biotech Inc. is registered with the SEC under industry code SIC 4581 (Airports, Flying Fields & Airport Terminal Services). Its shares trade on OTC under the ticker PHBI.

Is Pharmagreen Biotech Inc. profitable?

No. In fiscal 2022 it reported a net loss of $875.5K.

When did Pharmagreen Biotech Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2023. It covers the period to June 30, 2023. Its newest filing of any kind is the deregistration from December 1, 2023.

Similar companies

PAC

Pacific Airport Group

ASR

Southeast Airport Group

CAAP

Corporacion America Airports S.A.

OMAB

Central North Airport Group

SKAS

Saker Aviation Services, Inc.

TIWD

Timwood Holdings Ltd

Compare PHBI with

Compare PHBI with any company

Follow PHBI

Get an email when Pharmagreen Biotech Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow PHBI: get an email when it files

Where the numbers come from

Financial figures are the values Pharmagreen Biotech Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.